What is Nurix Therapeutics, Inc.'s accrued investment income?

Nurix Therapeutics, Inc. (NRIX) reported accrued investment income of $1.5M in Q3 2025.

What does accrued investment income mean?

This represents interest or other income earned on investment securities that has been recognized but not yet received in cash. It reflects the accrual of returns on the company's cash and investment balances. This metric is a component of working capital and indicates the efficiency of cash management.

Nurix Therapeutics, Inc. NRIX Accrued investment income

Accrued investment income at other companies

Stoke Therapeutics, Inc.STOK

$1.69M+179%

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$2B+40.1%

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestReceivableCurrent.

The official record: Nurix Therapeutics, Inc.’s 10-K, filed January 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s accrued investment income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s accrued investment income?: Nurix Therapeutics, Inc. (NRIX) reported accrued investment income of $1.5M in Q3 2025.
What does accrued investment income mean?: This represents interest or other income earned on investment securities that has been recognized but not yet received in cash. It reflects the accrual of returns on the company's cash and investment balances. This metric is a component of working capital and indicates the efficiency of cash management.